Results 111 to 120 of about 35,440 (172)

Future direction of systemic therapy for advanced renal cell carcinoma: lessons from final and extended follow-up data from the CheckMate 9ER trial. [PDF]

Transl Androl Urol
Ishihara H.
europepmc   +1 more source

Sunitinib induces immunogenic cell death through eIF2α phosphorylation to potentiate immunotherapy in HCC. [PDF]

iScience
Gu Y, Mai H, Huang P, Yuan H, Sun M, Gao H, Shang C, Ou Y, Liu T, Huang X, Tan J.   +10 more
europepmc   +1 more source

Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse Avatars. [PDF]

Cancers (Basel)
Bhattarai A, Moret R, Zhang X, Maresh G, Yip H, Haupt C, Graham R, Latsis M, Matrana M, Rose K, Bardot S, Li L.   +11 more
europepmc   +1 more source

Mapping the ATP-Binding Pockets of FLT3 and TAK1: A Structural Basis for Dual Inhibition by FLT3-Targeted Therapies. [PDF]

ACS Chem Biol
Haystead T, Freeze R, Liu G, Chen J, Hughes P, Scarneo S.   +5 more
europepmc   +1 more source

Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial. [PDF]

Cell Rep Med
Liu Y, Zhang XY, Wei WS, Liu RQ, Pan QW, Zhang YJ, Li JB, Peng YL, Huang TX, Zhang ZL, Han H, Guo SJ, Gao JM, Zhou FJ, Dong P, He LR.   +15 more
europepmc   +1 more source

CircGRHL2 suppresses EMT and enhances sunitinib sensitivity in ccRCC via the miR-330-5p/FBXO21 axis. [PDF]

Cell Mol Life Sci
Gao J, Yao H, Mao Q, Liu C, Cui Y, Zhao J, Ma J, Wu J.   +7 more
europepmc   +1 more source

Recurrent intracranial hemorrhage without brain metastasis after VEGFR TKI rechallenge in metastatic renal cell carcinoma: a case report and literature review. [PDF]

Front Oncol
Lee CH, Lee NR.
europepmc   +1 more source

Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods. [PDF]

Clin Pharmacokinet
Le Louedec F, Morvan L, Mourey L, Maillard M, Vachoux C, Yakoubi M, Tosi D, Gravis G, Roubaud G, Thuillier F, Boyle H, Thomas F, White-Koning M, Puisset F, Chatelut É.   +14 more
europepmc   +1 more source

Multi-target tyrosine kinase inhibitor-associated renal thrombotic microangiopathy: a pooled analysis of 31 cases. [PDF]

Front Pharmacol
Liu M, Zhou X.
europepmc   +1 more source

Elucidating the binding and metabolic interactions of sunitinib and sorafenib with Cytochrome P450s CYP2U1 and CYP2D6. [PDF]

Mol Pharmacol
Tang TY, Li Y, Chapman P, Tajkhorshid E, Das A.   +4 more
europepmc   +1 more source